SCHEMBL29316697

SCHEMBL29316697

CC(C)[C@@H]1CCN(C2CCCN(C)C2)C[C@@H]1F

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
KDM2B Q8NHM5 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25653333 0.85 KDM2B (0.39) KDM2B
SCHEMBL24185409 0.79 ALDH1A1 (0.32) KDM2B
SCHEMBL26743202 0.79 ALDH1A1 (0.32) KDM2B
SCHEMBL24185117 0.79 ALDH1A1 (0.32) KDM2B
SCHEMBL26743196 0.79 ALDH1A1 (0.32) KDM2B
SCHEMBL26743200 0.79 ALDH1A1 (0.32) KDM2B
SCHEMBL25506936 0.78 ATM (0.34)
SCHEMBL20697170 0.77 NCF1 (0.32)
SCHEMBL20697175 0.77 NCF1 (0.32)
SCHEMBL20697167 0.77 NCF1 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4397661-A1 COMPOUND FOR DEGRADATION OF BCL-2 FAMILY PROTEINS AND MEDICAL APPLICATION THEREOF Xizang Haisco Pharmaceutical Co., Ltd. (CN) 2024-07-10 EP disclosed